Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Technology & End-User The Global Breast Imaging market will witness a robust CAGR of 8.73%, valued at $4.50 billion in 2022 and expected to grow and reach $8.79 billion by 2030, confirms SMR. North America will continue to dominate the breast imaging industry, accounting for 39.47% of global sales. Breast imaging is a sub-specialty of diagnostic radiology that involves imaging of the breasts for screening or diagnostic purposes. There are different methods of breast imaging using multiple technologies, such as traditional screening and diagnostic mammography, breast tomosynthesis, xeromammography, galactography, breast ultrasound, breast MRI, and scintimammography. Conventional mammography uses X-ray technology, while breast tomosynthesis uses digital X-ray technology. Breast ultrasound can help differentiate between fluid-filled and solid lesions, while breast MRI is reserved for high-risk patients recently diagnosed with breast cancer. Scintimammography is used for patients with abnormal mammograms or whose screening is unreliable. The market is poised to be driven by factors like the rising prevalence of breast cancer, scientific advancements in breast imaging, and funding from numerous organizations for breast cancer screening programs. According to Cancer.Net, there are 3.8 million women with breast cancer in the USA, estimated to have 43,700 deaths in 2023. Breast imaging is the primary diagnosis of breast cancer globally, contributing to the growth of the breast imaging market. Technological advancements in screening for breast cancer have fuelled the development of the breast imaging market. Many campaigns and government initiatives are working towards breast cancer awareness because 90% of breast cancers are curable if detected early. AI technology is used with traditional methods to identify cancerous tumors, improving accuracy by 80%. Key Industry Drivers - Rising Incidence of Breast Cancer, Technological Advancements & Growth in Non-Invasive Procedures The increasing incidence of breast cancer significantly impacts the breast imaging market. Worldwide, breast cancer, the second most common cancer, affects millions of females annually. According to Cancer.Net, there are 3.8 mn breast cancer cases in the U.S., and the death toll is expected to reach 43,700 by 2023. The need for early detection and screening techniques has increased as breast cancer cases are increasing at an exponential rate. Breast imaging procedures, like mammography, ultrasound & MRI, are in high demand because they are necessary for the early detection & diagnosis of breast cancer. Technological Advancements act as a major driver for the breast imaging market. The introduction of technologies like digital mammography, tomosynthesis, contrast-enhanced mammography, molecular breast imaging, and breast-specific gamma imaging have improved breast cancer detection and diagnosis accuracy and reliability. These technological advancements have contributed to the market growth by providing healthcare providers with advanced tools for early detection and more precise evaluations of breast abnormalities. Digital mammography offers improved image quality, lower radiation doses, and the ability to store and transmit images electronically. The shift towards digital mammography has increased the efficiency of breast cancer screening programs & enabled the integration of computer-aided detection (CAD) systems to enhance diagnostic accuracy further. The increasing adoption of digital mammography systems has fuelled the growth of the breast imaging market. Integrating artificial intelligence (AI) & machine learning (ML) algorithms into breast imaging has opened up new possibilities for improving accuracy and efficiency. AI-based algorithms assist radiologists in detecting and characterizing breast abnormalities, reducing interpretation errors, and improving diagnostic outcomes. AI can also aid in risk assessment, predictive analytics, and prognosis prediction, contributing to personalized patient management. Integrating AI and ML in breast imaging is driving market growth by enhancing the capabilities and performance of imaging technologies. The demand for minimally invasive breast imaging procedures is another market driver. Minimally invasive techniques, such as image-guided biopsies, wire-localization procedures, and vacuum-assisted breast biopsies, offer less invasive alternatives as compared to traditional open surgical procedures. These procedures provide accurate targeting and sampling of breast lesions with minimal scarring and faster recovery times. The increasing patient preference for minimally invasive procedures has driven the demand for imaging technologies that support these techniques. Breast Imaging Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 4.14 billion The revenue forecast in 2030 USD 8.79 billion Growth rate CAGR of 8.73 % The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based on Technology, Based on End-User, and By region. Based on Technology Ionizing Breast Imaging (Mammography, Molecular Breast Imaging (MBI), Positron Emission Tomography-Computed Tomography (PET-CT), Cone-beam Computed Tomography (CBCT), Positron Emission Mammography (PEM) Non-ionizing Breast Imaging(Breast Ultrasound, Automated whole-breast Ultrasound (AWBU), Breast MRI, Electric Impedance Tomography, Breast thermography, Optical Imaging). Based on End-User Hospitals & Clinics, Diagnostic Imaging Centers, Breast Care Centers. By Region North America, Europe, Asia-Pacific, and LAMEA Country Scope US, Mexico, Canada, Germany, UK, France, China, Japan, India etc. Company Usability Profiles Hologic Inc., Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation, Canon Inc., Koninklijke Philips N.V., Aurora Healthcare US Corp., Allengers, Dilon Technologies, Inc., Planmed Oy, Delphinus Medical Technologies Inc., CMR Naviscan Corporation, Micrima Limited, SuperSonic Imagine, Carestream Health. Pricing and purchase options Customized buying options are available to meet your exact research needs. Restraints - Unawareness and Lack of Trained Professionals According to a study, 83% of the female population is unaware of breast imaging. The unawareness of breast cancer can have several implications, hindering the growth and adoption of breast imaging technologies. Unawareness of breast cancer symptoms, risk factors, and screening guidelines can lead to delayed or missed diagnoses, low screening rates, and limited adoption of advanced imaging technologies. This can impact the demand for breast imaging technologies and limit the market's growth potential. Public education, awareness campaigns, improved healthcare infrastructure, and better access to screening services are needed to increase awareness and drive the growth of the breast imaging market. Breast imaging modalities often require specialized training and expertise for accurate interpretation and optimal utilization. Radiologists and technologists must be proficient in specific imaging techniques, image interpretation, and recognition of subtle abnormalities. The demand for well-trained professionals can be a constraint, particularly in regions with a shortage of specialized healthcare providers. Training programs, continuing education, and skill development initiatives are essential to overcome this restraint and ensure quality breast imaging services. Opportunities - (AI & ML) Artificial Intelligence & Machine Learning have the potential to revolutionize breast imaging by improving diagnostic accuracy, computer-aided detection and diagnosis, personalized risk assessment and screening, workflow optimization and efficiency, and patient outcomes. AI and ML offer significant opportunities for breast imaging by improving diagnostic accuracy, enabling computer-aided detection and diagnosis, facilitating personalized risk assessment, optimizing workflow efficiency, and providing predictive analytics and prognosis. This serves as an opportunity in the Breast Imaging Market. Market Analysis Of Different Segments Covered in the Report Based on Technology Ionizing Breast Imaging Mammography o Full-field Digital Mammography (FFDM) o Analog Mammography o 3D Breast Tomosynthesis Molecular Breast Imaging (MBI) Positron Emission Tomography-Computed Tomography (PET-CT) Cone-beam Computed Tomography (CBCT) Positron Emission Mammography (PEM) Non-ionizing Breast Imaging Breast Ultrasound Automated whole-breast Ultrasound (AWBU) Breast MRI Electric Impedance Tomography Breast thermography Optical Imaging Based on End-User Hospitals & Clinics Diagnostic Imaging Centers Breast Care Centers Regional Coverage Analysis North America United States Mexico Canada Rest of North America Europe Switzerland Russia France Germany U.K Finland Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Indonesia South Korea Thailand Japan Singapore Malaysia Philippines Australia New Zealand Rest of APAC LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Segmentation Analysis & Insights Based on Technology, the breast imaging market is categorized into Ionizing & Non-Ionizing Breast Imaging Techniques. Ionizing Breast imaging dominates the market with a revenue share of 60% and is forecasted to grow. Based on Ionizing Breast Imaging, the market is categorized into Mammography, Molecular Breast Imaging (MBI), Positron Emission Tomography Computed Tomography (PET-CT), Cone-beam Computed Tomography (CBCT) & Positron Emission Mammography (PEM). Ionization in breast imaging refers to using ionizing radiation to produce images of the breast. This technique has gained importance in recent years due to several factors, such as accuracy, screening programs & advancements. Mammography is leading in the ionizing breast imaging segment because it reduces the death rate by 30% in early detection & it is a fast procedure and highly accurate. The mammography market is estimated to reach $4 billion by 2030. Based on Non-Ionizing Breast Imaging, the market is divided into Breast Ultrasound, Automated Whole Breast Ultrasound (AWBU), Electric Impedance Tomography, Breast MRI, Breast Thermography, & Optical Imaging. The breast ultrasound market is anticipated to hold the largest share due to the lower radiation exposure risk and several advantages, including detecting lesions, distinguishing between a cyst and a solid mass, and detecting blood flow through vessels. Breast ultrasound machines are widely available in different healthcare settings, including clinics, hospitals & imaging centres, making them highly accessible for routine screening & diagnostic purposes. Breast Ultrasound is cost-effective compared to MRI and other non-ionizing techniques. A recent advancement in breast ultrasound integrated with AI improved the accuracy by 25%. Based on end users, the breast imaging market is categorized into hospitals & clinics, diagnostic imaging, and breast care centres. Hospitals & Clinics are dominating the end-user segment of the breast imaging market with a revenue share of 47% and are expected to proliferate the need during the forecasted period. Hospitals and clinics offer various diagnostic services, including breast imaging, under one roof. They provide access to different imaging modalities such as mammography, ultrasound, MRI, and tomosynthesis. New technological advances and professional diagnoses provided by the hospital & clinics gave rise to the growth of the breast imaging segment. Breast Care Centres are the fastest growing segment due to awareness and early detection initiatives by breast care centres. Based on region, North America dominates the market share for breast imaging with a revenue share of 39.47% and will continue to dominate the market for the forecasted period, confirms Strategic Market Research. The rising incidence of breast cancer, massive R&D in breast cancer therapies, and advances in breast imaging technology are the significant drivers of this market. According to Cancer.Net, a total of 3.8 million females have breast cancer. Investment in breast cancer screening programs by various organizations also helps the market to expand. An organization in the US called the Society of Breast Imaging is dedicated towards minimizing the effects of breast cancer & saving patients' lives. The Asia-Pacific region shows the fastest growth in the breast imaging market with a CAGR of 9%, and the market will appreciate and reach $1 billion by the end of 2030. The driving factors contributing to the demand of the breast imaging market are the rising incidence of breast cancer, significant R&D investment in breast cancer therapies & advances in breast imaging technology. Breast cancer is the most recurrent cancer in many APAC countries like China, Korea, Japan, Singapore & Taiwan. The Centres for Disease Control (CDC) reviews that breast cancer is one of the most recurrent cancers in females regardless of their race & ethnicity. The rising ubiquity of breast cancer and the growing healthcare infrastructure in the region is expected to drive overall growth. The proliferating increase in the aging population is the other factor helping the development of the breast imaging market. The presence of market leaders such as Bayer AG, Pfizer Inc., Merck & Co., Inc., CooperSurgical, Inc., and Allergan PLC fuels the breast imaging market. Breast Imaging Market Competitive Landscape Analysis A thorough competitive landscape analysis provides the most appropriate information about the crucial competitors in the breast imaging market environment. The comparison is performed based on various market initiatives, investment in R&D, company overview, total revenue generation, market potential, company strengths and weaknesses, company financials, global presence, production capacity, production sites, and facilities. Hologic Inc. Siemens Healthineers GE Healthcare Fujifilm Holdings Corporation Canon Inc. Koninklijke Philips N.V. Aurora Healthcare US Corp. Allengers Dilon Technologies, Inc. Planmed Oy Delphinus Medical Technologies Inc. CMR Naviscan Corporation Micrima Limited SuperSonic Imagine Carestream Health Recent Developments On January 2023, A distributor contract was signed by Seno Medical & Genetik for the Imagio Opto-Acoustic/Ultrasound (OA/US) Breast Imaging System, which uses non-invasive OA/US technology to distinguish between benign and malignant breast lesions in real-time. The imaging system is recommended for adult patients who need to assess treatable breast abnormalities and those that are not. To help radiologists switch from ultrasound alone to OA/US imaging, which more precisely assigns malignancy likelihood, SenoGram, an AI decision-support tool, is available. On December 2022, MedCognetics developed QmTriage, a breast cancer-focused AI Platform, in partnership with the University of Texas Southwestern (UTSW) Medical Centre. It was trained using deidentified mammography scans from UTSW patients and achieved sensitivity and specificity of 87% and 89%, respectively, in a test set of 800 mammograms On November 2023, iCAD integrated Google Health's mammography AI technology into its breast imaging AI products. This integration marks Google's first commercial partnership for launching its breast imaging AI model into diagnostic practice. iCAD will confirm Google's mammography AI model & integrate it into ProFound AI in 2023, with a regulatory approval process required. Artificial Intelligence equipped medical devices will be sold to hospitals, health systems, and outpatient clinics. Google and iCAD have partnered to improve access to breast imaging AI technology. iCAD will use Google Cloud's infrastructure to deploy its technology, making it accessible to more women. iCAD is the only vendor offering a complete portfolio of AI, including breast cancer detection, automated breast density assessment, and a short-term breast cancer risk assessment AI tool with 80% accuracy. Frequently Asked Question About This Report Which is the leading End-User segment of the market? Based on End-User, the Hospitals & Clinics segment dominated the market in 2020 significantly with a steady CAGR value. How big is the breast imaging market? The global breast imaging market size was $ 4.14 Bn in 2021 and is predicted to reach $ 8.79 Bn by 2030, with a CAGR of 8.73 %. What are the breast imaging market growth? 8.73 % from 2021 to 2030 to reach USD 8.79 Billion by 2030. Which is the most dominant Technology in the market? Based on Technology, the Non-ionizing Breast Imaging segment dominated the market in 2020 with the highest CAGR during the estimated period. What is the most dominant region of the market? Based on Region, North America dominated the entire market comprehensively with a total share of 39.47% of the entire market in 2020 owing to the continuous rising cases of breast cancers. Who are the most crucial players in the market? The most vital players of the market are Hologic Inc, Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation, Canon Inc, Koninklijke Philips N.V, Aurora Healthcare US Corp, Allengers Dilon Technologies, Inc, Planmed Oy, Delphinus Medical Technologies Inc, CMR Naviscan Corporation, Micrima Limited, SuperSonic Imagine, and Carestream Health. Sources https://www.who.int/news-room/fact-sheets/detail/breast-cancer https://www.breastcancer.org/facts-statistics https://www.nationalbreastcancer.org/wp-content/uploads/2020-Breast-Cancer-Stats.pdf https://pubmed.ncbi.nlm.nih.gov/30207593/ https://medcitynews.com/2022/11/google-partners-with-icad-licenses-its-mammography-ai-model-for-the-first-time/ https://www.fiercebiotech.com/medtech/medcognetics-scores-fda-greenlight-breast-cancer-screening-ai https://www.medicaldevice-network.com/news/seno-medical-genetik-breast-imaging/ https://www.cdc.gov/cancer/breast/index.html https://www.cancer.net/cancer-types/breast-cancer/statistics https://www.emro.who.int/noncommunicable-diseases/campaigns/breast-cancer-month-2021.html https://www.sbi-online.org/ https://stanfordhealthcare.org/medical-clinics/breast-imaging-service/diagnostic-procedures.html https://www.breastcancer.org/screening-testing/mammograms/benefits-risks https://www.diagnosticimaging.com/view/breast-ultrasound-study-ai-bolsters-accuracy-and-specificity-of-bi-rads-classifications https://www.ncbi..nlm.nih.gov/pmc/ https://radiologykey.com/applications-of-artificial-intelligence-in-breast-imaging/ https://www.medicalnewstoday.com/articles/316632#mammography https://www.breastcancer.org/facts-statistics https://en.wikipedia.org/wiki/Breast_imaging https://www.cancer.net/cancer-types/breast-cancer/statistics 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Breast Imaging Market Snapshot 4.2 Global Market 4.2.1 Global Market, 2021 – 2028 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Market, by Region, 2021 - 2030 (USD Million) 4.4 End-User Business Analysis 4.4.1 Global Market, By End-User, 2021 - 2030 (USD Million) 4.5 Technology Business Analysis 4.5.1 Global Market, By Technology, 2021 - 2030 (USD Million) 4.6 Value Chain Analysis 4.7 Market Variable Analysis 4.7.1 Market Drivers Analysis 4.7.2 Market Restraints Analysis 4.8 Business Environment Analysis Tool 4.8.1 Market PEST analysis 4.8.2 Market Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2021) 5.11.2. Trends in Technology (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Breast Imaging Manufacturing Sites, Area Served, End-User 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By End-User Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Hospitals & Clinics 7.3.1. Hospitals & clinics Market, 2021 - 2030 (USD Million) 7.4. Diagnostic Imaging Centers 7.4.1. Diagnostic Imaging Centers Market, 2021 - 2030 (USD Million) 7.5 Breast Care Centers 7.5.1 Breast Care Centers market, 2021 - 2030 (USD Million) 8. Global Market: By Technology Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Ionizing Breast Imaging 8.3.1. Ionizing Market, 2021 - 2030 (USD Million) 8.3.1.1. Mammography market, 2021 - 2030 (USD Million) 8.3.1.1.1. Full-field Digital Mammography (FFDM) market, 2021 - 2030 (USD Million) 8.3.1.1.2. Analog Mammography market, 2021 - 2030 (USD Million) 8.3.1.1.3 3D Breast Tomosynthesis market, 2021 - 2030 (USD Million) 8.3.1.2. Molecular Breast Imaging (MBI) market, 2021 - 2030 (USD Million) 8.3.1.3. Positron Emission Tomography-Computed Tomography (PET-CT) market, 2021 - 2030 (USD Million) 8.3.1.4. Cone-beam Computed Tomography (CBCT) market, 2021 - 2030 (USD Million) 8.3.1.5. Positron Emission Mammography (PEM) market, 2021 - 2030 (USD Million) 8.4. Non-ionizing Breast Imaging 8.4.1. Non-ionizing Market, 2021 - 2030 (USD Million) 8.4.1.1. Breast Ultrasound market, 2021 - 2030 (USD Million) 8.4.1.2. Automated whole-breast Ultrasound (AWBU) market, 2021 - 2030 (USD Million) 8.4.1.3. Breast MRI market, 2021 - 2030 (USD Million) 8.4.1.4. Electric Impedance Tomography market, 2021 - 2030 (USD Million) 8.4.1.5. Breast thermography market, 2021 - 2030 (USD Million) 8.4.1.6. Optical Imaging market, 2021 - 2030 (USD Million) 9. Global Market: Regional Outlook 9.1 North America 9.1.1. North America Market, By End-User, 2021 - 2030 (USD Million) 9.1.4. North America Market, By Technology, 2021 - 2030 (USD Million) 9.1.5. North America Market, by Country, 2021 - 2030 (USD Million) 9.1.4.1. U.S. 9.1.4.1.1. U.S. Market, By End-User, 2021 - 2030 (USD Million) 9.1.4.2. Canada 9.1.4.2.1. Canada Market, By End-User, 2021 - 2030 (USD Million) 9.1.4.2.2. Canada Market, By Region, 2021 - 2030 (USD Million) 9.1.4.2.3. Canada Market, by Technology, 2021 - 2030 (USD Million) 9.2. Europe 9.2.1. Europe Market, By End-User, 2021 - 2030 (USD Million) 9.2.2. Europe Market, by By Technology, 2021 - 2030 (USD Million) 9.2.5. Europe Market, by country, 2021 - 2030 (USD Million) 9.2.4.1 U.K. 9.2.4.1.1. U.K. Market, By End-User, 2021 - 2030 (USD Million) 9.2.4.1.2. U.K. Market, By Technologys, 2021 - 2030 (USD Million) 9.2.4.1.3. U.K. Market, by Region, 2021 - 2030 (USD Million) 9.2.4.2. Germany 9.2.4.2.1. Germany Market, By End-User, 2021 - 2030 (USD Million) 9.2.4.2.2. Germany Market, By Technology, 2021 - 2030 (USD Million) 9.2.4.2.3. Germany Market, by Region, 2021 - 2030 (USD Million) 9.2.4.3. France 9.2.4.3.1. France Market, By End-User, 2021 - 2030 (USD Million) 9.2.4.3.2. France Market, By Region, 2021 - 2030 (USD Million) 9.2.4.3.3. France Market, by Technology, 2021 - 2030 (USD Million) 9.2.4.4. Rest of Europe 9.2.4.4.1. Rest of Europe Market, By End-User, 2021 - 2030 (USD Million) 9.2.4.4.2. Rest of Europe Market, By Region, 2021 - 2030 (USD Million) 9.2.4.4.3. Rest of Europe Market, by Technology, 2021 - 2030 (USD Million) 9.3. Asia Pacific 9.3.1. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 9.3.2. Asia Pacific Market, By Technology, 2021 - 2030 (USD Million) 9.3.5. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 9.3.4.1. China 9.3.4.1.1. China Market, By End-User, 2021 - 2030 (USD Million) 9.3.4.1.2. China Market, By Region, 2021 - 2030 (USD Million) 9.3.4.1.3. China Market, by Technology, 2021 - 2030 (USD Million) 9.3.4.2. India 9.3.4.2.1. India Market, By End-User, 2021 - 2030 (USD Million) 9.3.4.2.2. India Market, By Region, 2021 - 2030 (USD Million) 9.3.4.2.3. India Market, by Technology, 2021 - 2030 (USD Million) 9.3.4.3. Japan 9.3.4.3.1. Japan Market, By End-User, 2021 - 2030 (USD Million) 9.3.4.3.3. Japan Market, by Technology, 2021 - 2030 (USD Million) 9.3.4.4. South Korea 9.3.4.4.1. South Korea Market, By End-User, 2021 - 2030 (USD Million) 9.3.4.4.3. South Korea Market, by Technology, 2021 - 2030 (USD Million) 9.3.4.5. Rest of ASIA PACIFIC 9.3.4.5.1. Rest of ASIA PACIFIC Market, By End-User, 2021 - 2030 (USD Million) 9.3.4.5.3. Rest of ASIA PACIFIC Market, by Technology, 2021 - 2030 (USD Million) 9.4. Latin America 9.4.1. Latin America Market, By End-User, 2021 - 2030 (USD Million) 9.4.3. Latin America Market, by Technology, 2021 - 2030 (USD Million) 9.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 9.4.4.1. Brazil 9.4.4.1.1. Brazil Market, By End-User, 2021 - 2030 (USD Million) 9.4.4.1.3. Brazil Market, by Technology, 2021 - 2030 (USD Million) 9.4.4.2. Mexico 9.4.4.2.1. Mexico Market, By End-User, 2021 - 2030 (USD Million) 9.4.4.2.3. Mexico Market, by Technology, 2021 - 2030 (USD Million) 9.4.4.3. Rest of the Latin America 9.4.4.3.1. Rest of the Latin America Market, By End-User, 2021 - 2030 (USD Million) 9.4.4.3.3. Rest of the Latin America Market, by Technology, 2021 - 2030 (USD Million) 10. Competitive Landscape 10.1 Hologic Inc. 10.1.1. Company overview 10.1.2. Financial performance 10.1.3. Technology Portfolio Analysis 10.1.4. Business Strategy & Recent Development 10.2. Siemens Healthineers 10.2.1. Company overview 10.2.2. Financial performance 10.2.3. Technology Portfolio Analysis 10.2.4. Business Strategy & Recent Development 10.3. GE Healthcare. 10.3.1. Company overview 10.3.2. Financial performance 10.3.3. Technology Portfolio Analysis 10.3.4. Business Strategy & Recent Development 10.4. Fujifilm Holdings Corporation. 10.4.1. Company overview 10.4.2. Financial performance 10.4.3. Technology Portfolio Analysis 10.4.4. Business Strategy & Recent Development 10.5. Canon Inc. 10.5.1. Company overview 10.5.2. Financial performance 10.5.3. Technology Portfolio Analysis 10.5.4. Business Strategy & Recent Development 10.6. Koninklijke Philips N.V. 10.6.1. Company overview 10.6.2. Financial performance 10.6.3. Technology Portfolio Analysis 10.6.4. Business Strategy & Recent Development 10.7. Aurora Healthcare US Corp. 10.7.1. Company overview 10.7.2. Financial performance 10.7.3. Technology Portfolio Analysis 10.7.4. Business Strategy & Recent Development 10.8. Allengers. 10.8.1. Company overview 10.8.2. Financial performance 10.8.3. Technology Portfolio Analysis 10.8.4. Business Strategy & Recent Development 10.9. Dilon Technologies, Inc. 10.9.1. Company overview 10.9.2. Financial performance 10.9.3. Product Portfolio Analysis 10.9.4. Business Strategy & Recent Development 10.10. Planmed Oy. 10.10.1. Company overview 10.10.2. Financial performance 10.10.3. Product Portfolio Analysis 10.10.4. Business Strategy & Recent Development 10.11. Delphinus Medical Technologies Inc. 10.11.1. Company overview 10.11.2. Financial performance 10.11.3. Product Portfolio Analysis 10.11.4. Business Strategy & Recent Development 10.12. CMR Naviscan Corporation. 10.12.1. Company overview 10.12.2. Financial performance 10.12.3. Product Portfolio Analysis 10.12.4. Business Strategy & Recent Development 10.13. Micrima Limited. 10.13.1. Company overview 10.13.2. Financial performance 10.13.3. Product Portfolio Analysis 10.13.4. Business Strategy & Recent Development 10.14. SuperSonic Imagine. 10.14.1. Company overview 10.14.2. Financial performance 10.14.3. Product Portfolio Analysis 10.14.4. Business Strategy & Recent Development 10.15. Carestream Health. 10.15.1. Company overview 10.15.2. Financial performance 10.15.3. Product Portfolio Analysis 10.15.4. Business Strategy & Recent Development List of Tables (67 Tables) TABLE 1. Market, By End-User, 2021-2030 (USD Million) TABLE 2. Market FOR Hospitals & Clinics, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Diagnostic Imaging Centers, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Breast Care Centers, BY REGION, 2021-2030 (USD Million) TABLE 6. Market, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 7. Market FOR Ionizing Breast Imaging, BY REGION, 2021-2030 (USD Million) TABLE 8. Market FOR Mammography, BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Full-field Digital Mammography (FFDM), BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Analog Mammography, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR 3D Breast Tomosynthesis, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Molecular Breast Imaging (MBI), BY REGION, 2021-2030 (USD Million) TABLE 13. Market FOR Positron Emission Tomography-Computed Tomography (PET-CT), BY REGION, 2021-2030 (USD Million) TABLE 14. Market FOR Cone-beam Computed Tomography (CBCT), BY REGION, 2021-2030 (USD Million) TABLE 15. Market FOR Positron Emission Mammography (PEM), BY REGION, 2021-2030 (USD Million) TABLE 16. Market FOR Non-ionizing Breast Imaging, BY REGION, 2021-2030 (USD Million) TABLE 17. Market FOR Breast Ultrasound, BY REGION, 2021-2030 (USD Million) TABLE 18. Market FOR Automated whole-breast Ultrasound (AWBU), BY REGION, 2021-2030 (USD Million) TABLE 19. Market FOR Breast MRI, BY REGION, 2021-2030 (USD Million) TABLE 20. Market FOR Electric Impedance Tomography, BY REGION, 2021-2030 (USD Million) TABLE 21. Market FOR Breast thermography, BY REGION, 2021-2030 (USD Million) TABLE 22. Market FOR Optical Imaging, BY REGION, 2021-2030 (USD Million) TABLE 23. Market, BY REGION, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA Market, BY Technologys, 2021-2030 (USD Million) TABLE 26. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 27. NORTH AMERICA Market, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 28. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 29. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 30. EUROPE Market, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 34. ASIA-PACIFIC Market, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 35. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 36. LAMEA Market, By End-User, 2021-2030 (USD Million) TABLE 37. LAMEA Market, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 38. Hologic Inc: COMPANY SNAPSHOT TABLE 39. Hologic Inc: OPERATING SEGMENTS TABLE 40. Siemens Healthineers: COMPANY SNAPSHOT TABLE 41. Siemens Healthineers: OPERATING SEGMENTS TABLE 42. GE Healthcare: COMPANY SNAPSHOT TABLE 43. GE Healthcare: OPERATING SEGMENTS TABLE 44. Fujifilm Holdings Corporation: COMPANY SNAPSHOT TABLE 45. Fujifilm Holdings Corporation: OPERATING SEGMENTS TABLE 46. Canon Inc: COMPANY SNAPSHOT TABLE 47. Canon Inc: OPERATING SEGMENTS TABLE 48. Koninklijke Philips N.V.: COMPANY SNAPSHOT TABLE 49. Koninklijke Philips N.V.: OPERATING SEGMENTS TABLE 50. Aurora Healthcare US Corp: COMPANY SNAPSHOT TABLE 51. Aurora Healthcare US Corp: OPERATING SEGMENTS TABLE 52. Allengers: COMPANY SNAPSHOT TABLE 53. Allengers: OPERATING SEGMENTS TABLE 54. Dilon Technologies, Inc: COMPANY SNAPSHOT TABLE 55. Dilon Technologies, Inc: OPERATING SEGMENTS TABLE 56. Planmed Oy: COMPANY SNAPSHOT TABLE 57. Planmed Oy: OPERATING SEGMENTS TABLE 58. Delphinus Medical Technologies Inc: COMPANY SNAPSHOT TABLE 59. Delphinus Medical Technologies Inc: OPERATING SEGMENTS TABLE 60. CMR Naviscan Corporation: COMPANY SNAPSHOT TABLE 61. CMR Naviscan Corporation: OPERATING SEGMENTS TABLE 62. Micrima Limited: COMPANY SNAPSHOT TABLE 63. Micrima Limited: OPERATING SEGMENTS TABLE 64. SuperSonic Imagine: COMPANY SNAPSHOT TABLE 65. SuperSonic Imagine: OPERATING SEGMENTS TABLE 66. Carestream Health: COMPANY SNAPSHOT TABLE 67. Carestream Health: OPERATING SEGMENTS List of Figures (20 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Technology-Based Estimation